BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 18, 2009
View Archived Issues
Propiverine shows good combination of efficacy and tolerability in neurogenic detrusor overactivity
Read More
NB-001 deemed safe and efficacious in patients with recurrent herpes labialis
Read More
Results from the SATORI study with tocilizumab in RA patients disclosed
Read More
Prolonged-release ropinirole improves symptom control in Parkinson's patients
Read More
Servier claims novel napthalene derivatives that inhibit melatonin receptors
Read More
Memantine beneficial in patients with Parkinson's disease dementia or dementia with Lewy bodies
Read More
Chiesi describes new PDE4 inhibitors useful for asthma and other respiratory disorders
Read More
Boehringer Ingelheim reports quinazolinedione chymase inhibitors for cardiovascular disorders
Read More
New compounds for bacterial infections under development at AstraZeneca
Read More
Taisho and Meiji Seika present novel antibacterial agents
Read More
New cytochrome P450 inhibitors for HIV infections claimed by Gilead
Read More
Emergent BioSolutions commences phase I/II anthrax immune globulin trial
Read More
Last patient visit completed in Kamada's phase II inhaled AAT bronchiectasis study
Read More
Allos Therapeutics' pralatrexate granted European orphan drug designation for bladder cancer
Read More
Synta initiates phase I/II clinical trial of STA-9090 in hematologic malignancies
Read More
Tepnel shareholders approve acquisition by Gen-Probe
Read More
Biotec completes patient inclusion in its first phase III diabetic ulcer study
Read More
Compugen's Relaxin receptor peptide ligand shows efficacy in pulmonary fibrosis animal model
Read More
MannKind submits NDA for Afresa for the treatment of diabetes
Read More
Melior Discovery advances MLR-1023 into clinical studies
Read More
MiddleBrook launches Moxatag (once-daily amoxicillin)
Read More
Prometheus Laboratories receives New York State approval for IBS diagnostic Prometheus
Read More
CytRx's arimoclomol improves stroke recovery in preclinical trial in rats
Read More
Cordis initiates NEVO II clinical trial comparing Nevo and Xience V coronary stents
Read More
Synairgen presents update on phase I SG004 clinical trial of IFN-beta in asthmatic volunteers
Read More
